GEODE CAPITAL MANAGEMENT, LLC - COHERUS BIOSCIENCES INC ownership

COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 184 filers reported holding COHERUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of COHERUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$7,275,056
+19.9%
1,944,967
+36.9%
0.00%0.0%
Q2 2023$6,065,996
-32.2%
1,420,608
+8.6%
0.00%0.0%
Q1 2023$8,949,250
+89553.9%
1,308,370
+3.8%
0.00%0.0%
Q4 2022$9,982
-99.9%
1,260,420
+2.5%
0.00%
-50.0%
Q3 2022$11,812,000
+36.3%
1,229,209
+2.7%
0.00%
+100.0%
Q2 2022$8,665,000
-42.5%
1,196,852
+2.5%
0.00%
-50.0%
Q1 2022$15,079,000
-20.9%
1,168,056
-2.2%
0.00%0.0%
Q4 2021$19,068,000
-0.9%
1,194,760
-0.3%
0.00%
-33.3%
Q3 2021$19,248,000
+17.6%
1,197,784
+1.2%
0.00%
+50.0%
Q2 2021$16,368,000
+1.9%
1,183,568
+7.7%
0.00%0.0%
Q1 2021$16,060,000
-6.4%
1,099,311
+11.3%
0.00%
-33.3%
Q4 2020$17,162,000
-2.3%
987,470
+3.1%
0.00%0.0%
Q3 2020$17,570,000
+3.0%
958,060
+0.3%
0.00%
-25.0%
Q2 2020$17,055,000
+8.5%
954,959
-1.4%
0.00%0.0%
Q1 2020$15,716,000
-51.2%
968,982
-45.8%
0.00%
+33.3%
Q4 2019$32,198,000
+85.5%
1,788,292
+108.8%
0.00%
-25.0%
Q3 2019$17,354,000
-0.7%
856,569
+8.3%
0.00%0.0%
Q2 2019$17,480,000
+83.9%
790,963
+13.5%
0.00%
+100.0%
Q1 2019$9,506,000
-16.7%
696,985
-44.7%
0.00%0.0%
Q4 2018$11,410,000
+8.8%
1,260,950
+98.3%
0.00%
-33.3%
Q3 2018$10,490,000
+47.7%
635,814
+25.3%
0.00%
+50.0%
Q2 2018$7,103,000
+47.3%
507,425
+16.3%
0.00%0.0%
Q1 2018$4,821,000
+40.8%
436,328
+12.2%
0.00%
+100.0%
Q4 2017$3,423,000
-32.4%
389,013
+2.5%
0.00%
-50.0%
Q3 2017$5,064,000
+9.2%
379,392
+17.4%
0.00%0.0%
Q2 2017$4,636,000
-19.6%
323,126
+18.5%
0.00%0.0%
Q1 2017$5,768,000
-14.1%
272,749
+14.3%
0.00%
-33.3%
Q4 2016$6,716,000
+16.1%
238,610
+10.4%
0.00%0.0%
Q3 2016$5,787,000
+66.8%
216,161
+5.2%
0.00%
+50.0%
Q2 2016$3,470,000
+60.7%
205,465
+102.0%
0.00%
+100.0%
Q1 2016$2,159,000
+1.4%
101,713
+9.6%
0.00%0.0%
Q4 2015$2,130,000
+18.8%
92,778
+3.7%
0.00%0.0%
Q3 2015$1,793,000
-28.4%
89,487
+3.3%
0.00%0.0%
Q2 2015$2,503,000
+32.9%
86,616
+40.6%
0.00%0.0%
Q1 2015$1,883,000
+211.2%
61,593
+65.9%
0.00%
Q4 2014$605,00037,1270.00%
Other shareholders
COHERUS BIOSCIENCES INC shareholders Q1 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 568,408$2,125,84618.08%
CM Management, LLC 548,000$2,049,5202.18%
AlphaCentric Advisors LLC 912,500$3,412,7501.94%
Knott David M Jr 630,000$2,3560.90%
COURAGE CAPITAL MANAGEMENT LLC 50,000$1870.63%
Bridge City Capital, LLC 276,224$1,033,0780.52%
Kohlberg Kravis Roberts & Co. L.P. 3,036,076$11,354,9240.40%
Ikarian Capital, LLC 865,787$3,238,0430.39%
Aristotle Capital Boston, LLC 2,342,977$8,762,7340.28%
TANG CAPITAL MANAGEMENT LLC 400,000$1,496,0000.21%
View complete list of COHERUS BIOSCIENCES INC shareholders